<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03967210</url>
  </required_header>
  <id_info>
    <org_study_id>KlebsieLCR</org_study_id>
    <nct_id>NCT03967210</nct_id>
  </id_info>
  <brief_title>Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis</brief_title>
  <acronym>KlebsieLCR</acronym>
  <official_title>Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Klebsiella pneumoniae is implicated in the occurrence of severe pneumonia. Most Klebsiella
      pneumoniae infections are associated with care and occur in patients with compromised immune
      defenses. More recently, cases of hepatic abscess and acute community meningitis related to
      strains of Klebsiella pneumoniae have been reported. The mortality of these infections is
      important, most often due to a delayed diagnosis. The poor prognostic factors reported in the
      literature for very low numbers are: advanced age, coma, septic shock, glyceryachia &lt;10mg /
      dL and proteinuria&gt; 750 mg / dL. In addition, no study has specifically focused on the
      factors of occurrence and factors associated with Klebsiella sp. Indeed, meningitis related
      to Klebsiella pneumoniae seems to be a rare but probably underestimated event whose risk
      factors, clinical presentation, microbiological are little known and the treatment modalities
      of this severe infection are not codified.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterize meningitis with Klebsiella pneumoniae</measure>
    <time_frame>Day 1</time_frame>
    <description>This corresponds to characterize Klebsiella pneumoniae meningitis, portal entry, secondary infection, associated antibiotic and associated therapies and the clinical course of patients.</description>
  </primary_outcome>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Meningitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with meningitis Klebsiella sp., hospitalized in one of the hospitals of the
        Clinical Microbiology Group between 2008 and 2018.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or Woman whose age ≥ 18 years

          -  Patient with meningitis Klebsiella sp., hospitalized in one of the hospitals of the
             Clinical Microbiology Group

          -  Francophone patient

        Exclusion Criteria:

          -  Patient under tutorship or curatorship

          -  Patient deprived of liberty

          -  Patient under safeguard of justice

          -  Patient opposing his participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benoit PILMIS, MD</last_name>
    <role>Study Director</role>
    <affiliation>Groupe Hospitalier Paris Saint Joseph</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benoit PILMIS, MD</last_name>
    <phone>0144127820</phone>
    <phone_ext>+33</phone_ext>
    <email>bpilmis@hpsj.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helene P BEAUSSIER, PharmD, PhD</last_name>
    <phone>0144127883</phone>
    <phone_ext>+33</phone_ext>
    <email>crc@hpsj.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Genevieve Hery Arnaud</last_name>
      <email>Genevieve.hery-arnaud@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Genevieve Hery Arnaud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Isnard</last_name>
      <email>Christophe.isnard@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe Isnard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital henri Mondor</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Fihman</last_name>
      <email>Vincent.fihman@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Fihman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>frederic Laurent</last_name>
      <email>Frederic.laurent@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Frederic Laurent</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Corvec, MD</last_name>
      <email>stephane.corvec@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphane Corvec, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Legrand</last_name>
      <email>nicolas.degand@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas Legrand</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé Jacquier, MD</last_name>
      <email>hervé.jacquier@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé Jacquier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Paris Saint-Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Groupe Hospitalier P Saint-Joseph</last_name>
      <phone>144127038</phone>
      <email>crc@hpsj.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Morand, MD</last_name>
      <email>phillipe.morand@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Morand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Kremlin Bicetre</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Dortet</last_name>
      <email>laurent.dortet@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent Dortet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Farfour</last_name>
      <email>eric.farfour@hopitalfoch.org</email>
    </contact>
    <investigator>
      <last_name>Eric Farfour</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle Bille</last_name>
      <email>Emmanuelle.bille@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuelle Bille</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Sainte Anne</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Schimpf</last_name>
    </contact>
    <investigator>
      <last_name>Caroline Schimpf</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chloé Plouzeau</last_name>
      <email>chloe.plouzeau@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Chloé Plouzeau</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Reims</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Guillard, MD</last_name>
      <email>thomas.guillard@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas Guillard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent P Cattoir, MD</last_name>
      <phone>02 99 28 42 76</phone>
      <phone_ext>+33</phone_ext>
      <email>vincent.cattoir@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Cattoir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Grillon, MD</last_name>
      <email>Antoine.grillon@chu-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Antoine Grillon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile Le Brun</last_name>
      <email>cécile.lebrun@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile Le Brun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 24, 2019</study_first_submitted>
  <study_first_submitted_qc>May 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningococcal Infections</mesh_term>
    <mesh_term>Meningitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

